HealthInvest Partners AB Diversified Active

CIK: 0001381843 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 9, 2018

Total Value ($000): $47,385 (100.0% shares, 0.0% debt)

Holdings (16)

ANIK ANIKA THERAPEUTICS INC 13.0%
Value ($000) $6,178 Shares 114,600 Est. Cost $38.78 Unrealized +42.7%
CRL CHARLES RIV LABS INTL INC 6.2%
Value ($000) $2,924 Shares 26,712 Est. Cost $63.72 Unrealized +70.8%
LABORATORY CORP AMER HLDGS 6.0%
Value ($000) $2,839 Shares 17,800 Est. Cost $154.15 Unrealized
DGX QUEST DIAGNOSTICS INC 5.9%
Value ($000) $2,807 Shares 28,500 Est. Cost $80.65 Unrealized 0.0%
CAH CARDINAL HEALTH INC 5.9%
Value ($000) $2,794 Shares 45,600 Est. Cost $48.46 Unrealized 0.0%
MCK MCKESSON CORP 5.9%
Value ($000) $2,776 Shares 17,800 Est. Cost $138.41 Unrealized +0.4%
ELV ANTHEM INC 5.8%
Value ($000) $2,768 Shares 12,300 Est. Cost $160.37 Unrealized +19.4%
LGND LIGAND PHARMACEUTICALS INC 5.8%
Value ($000) $2,766 Shares 20,200 Est. Cost $69.95 Unrealized +23.9%
MDT MEDTRONIC PLC 5.8%
Value ($000) $2,762 Shares 34,200 Est. Cost $66.95 Unrealized -3.0%
CIGNA CORPORATION 5.7%
Value ($000) $2,721 Shares 13,400 Est. Cost $186.93 Unrealized
PFE PFIZER INC 5.7%
Value ($000) $2,720 Shares 75,100 Est. Cost $21.60 Unrealized +10.2%
WAT WATERS CORP 5.7%
Value ($000) $2,705 Shares 14,000 Est. Cost $181.32 Unrealized +6.5%
LLY LILLY ELI & CO 5.7%
Value ($000) $2,703 Shares 32,000 Est. Cost $75.28 Unrealized 0.0%
BIIB BIOGEN INC 5.6%
Value ($000) $2,676 Shares 8,400 Est. Cost $264.42 Unrealized +21.3%
BMY BRISTOL MYERS SQUIBB CO 5.6%
Value ($000) $2,660 Shares 43,400 Est. Cost $46.46 Unrealized 0.0%
GILD GILEAD SCIENCES INC 5.5%
Value ($000) $2,586 Shares 36,100 Est. Cost $53.11 Unrealized +5.3%